Emcure Pharmaceuticals gets nod to incorporate wholly-owned subsidiary

14 Sep 2024 Evaluate

Emcure Pharmaceuticals has received approval for the incorporation of a wholly-owned subsidiary (WOS) by the name ‘Emcutix Biopharmaceuticals’ in Pune, Maharashtra, India. WoS is being incorporated to manufacture, promote, sale and distribute pharmaceuticals and other related product(s).  A Committee of the Board of Directors of the Company in their meeting held on September 13, 2024, has inter-alia approved the same. 

Emcure Pharmaceuticals is one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.


Emcure Pharma Share Price

1040.35 12.55 (1.22%)
28-Apr-2025 10:47 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1827.80
Dr. Reddys Lab 1199.65
Cipla 1552.50
Lupin 2101.00
Zydus Lifesciences 874.55
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...